Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.29 USD | -3.56% | +2.16% | -11.67% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.67% | 498M | |
+7.77% | 113B | |
+10.39% | 106B | |
+0.41% | 22.27B | |
-11.99% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.22% | 17.24B | |
+6.52% | 14.29B | |
+36.22% | 12.52B |
- Stock Market
- Equities
- URGN Stock
- News UroGen Pharma Ltd.
- Transcript : UroGen Pharma Ltd. - Special Call